A polyepitope DNA vaccine targeted to Her-2/ErbB-2 elicits a broad range of human and murine CTL effectors to protect against tumor challenge.
Scardino A, Alimandi M, Correale P, Smith SG, Bei R, Firat H, Cusi MG, Faure O, Graf-Dubois S, Cencioni G, Marrocco J, Chouaib S, Lemonnier FA, Jackson AM, Kosmatopoulos K.
Scardino A, et al. Among authors: chouaib s.
Cancer Res. 2007 Jul 15;67(14):7028-36. doi: 10.1158/0008-5472.CAN-06-3998.
Cancer Res. 2007.
PMID: 17638916